1. Home
  2. VCEL vs SXT Comparison

VCEL vs SXT Comparison

Compare VCEL & SXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • SXT
  • Stock Information
  • Founded
  • VCEL 1989
  • SXT 1882
  • Country
  • VCEL United States
  • SXT United States
  • Employees
  • VCEL N/A
  • SXT N/A
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • SXT Major Chemicals
  • Sector
  • VCEL Health Care
  • SXT Industrials
  • Exchange
  • VCEL Nasdaq
  • SXT Nasdaq
  • Market Cap
  • VCEL 2.8B
  • SXT 2.9B
  • IPO Year
  • VCEL 1997
  • SXT N/A
  • Fundamental
  • Price
  • VCEL $59.07
  • SXT $73.72
  • Analyst Decision
  • VCEL Strong Buy
  • SXT Buy
  • Analyst Count
  • VCEL 7
  • SXT 1
  • Target Price
  • VCEL $62.29
  • SXT $85.00
  • AVG Volume (30 Days)
  • VCEL 424.2K
  • SXT 213.1K
  • Earning Date
  • VCEL 02-27-2025
  • SXT 02-14-2025
  • Dividend Yield
  • VCEL N/A
  • SXT 2.23%
  • EPS Growth
  • VCEL N/A
  • SXT N/A
  • EPS
  • VCEL 0.07
  • SXT 2.09
  • Revenue
  • VCEL $226,844,000.00
  • SXT $1,530,110,000.00
  • Revenue This Year
  • VCEL $23.82
  • SXT $8.14
  • Revenue Next Year
  • VCEL $22.51
  • SXT $4.13
  • P/E Ratio
  • VCEL $821.76
  • SXT $35.24
  • Revenue Growth
  • VCEL 22.48
  • SXT 5.10
  • 52 Week Low
  • VCEL $38.69
  • SXT $55.02
  • 52 Week High
  • VCEL $61.49
  • SXT $82.99
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 57.96
  • SXT 54.47
  • Support Level
  • VCEL $53.00
  • SXT $66.15
  • Resistance Level
  • VCEL $60.93
  • SXT $70.68
  • Average True Range (ATR)
  • VCEL 2.60
  • SXT 1.44
  • MACD
  • VCEL -0.06
  • SXT 0.52
  • Stochastic Oscillator
  • VCEL 76.54
  • SXT 99.28

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in various therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.

About SXT Sensient Technologies Corporation

Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. The company has a widespread network of facilities around the globe, and its customers operate across a variety of end markets. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. The company's principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's three reportable segments were the Flavors & Extracts Group, the Color Group, and the Asia Pacific Group.

Share on Social Networks: